MarketNews

US tissue market relies on imports to meet domestic demand

The United States is expected to consume 9.06 million tonnes of tissue this year, while domestic production remains insufficient to meet demand. Imports, particularly from Asia, continue to fill the supply gap

The United States remains a net importer of tissue, requiring approximately 1 million tonnes of imports annually to bridge the gap between domestic production and consumption. With local supply unable to meet the population’s needs, dependence on foreign products also contributes to higher prices for American consumers.

US tissue demand is expected to reach 9.06 million tonnes in 2026, equivalent to an average annual consumption of 27 kg per capita. By comparison, per capita consumption in China stands at 9 kg. Although North America is no longer the world’s largest tissue market, it remains the second largest, with the United States accounting for a significant share of regional demand.

Asia is the leading source of tissue imports into North America, with Indonesia and China ranking among the largest exporters. China continues to supply the US market despite tariffs of 37.5% on certain products.

The impact of the 50% tariff imposed on Canadian products was also assessed as unlikely to cause supply shortages. Tissue shipments from Canada account for just 4.9% of US consumption. Furthermore, in a global market characterized by excess supply, importers can redirect purchases from Canada to suppliers in other regions.

PRODUCTION COSTS AND COMPETITIVENESS

The reliance on imports is also linked to differences in production costs. Tissue manufacturing costs in North America are higher than those in Latin America and China, reflecting two main factors.

In Latin America, new integrated projects have strengthened the region’s production competitiveness. In China, meanwhile, tissue machines are more heavily concentrated on conventional manufacturing processes, which require less energy than Through-Air-Dried (TAD) technology, widely used in North America.

NEW CAPACITY COULD REDUCE IMPORT DEPENDENCE

The outlook suggests that US tissue imports could decline once the new production capacity announced by manufacturers begins operating. Until then, however, foreign suppliers are expected to remain essential to meeting domestic demand.

Tariffs can increase the cost of imported products and, consequently, the price consumers pay to cover the supply shortfall. However, they do not eliminate the underlying gap between domestic production and consumption when local manufacturing capacity remains insufficient.

Show More
Back to top button
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.